Philip D. Worboys, SVP, Research & Transl Science at Theravance Biopharma, Inc. (TBPH), sold 21,907 shares at $18.00 ($395K) on 2020-08-20, disclosed to the SEC on 2020-08-24.
Seasonal sale ($395k) by SVP, Research & Transl Science — this insider has traded TBPH in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 17,103 | $308K | 77.9% |
| 2 | $18.22 | 4,804 | $88K | 22.1% |
| Total | $18.05 avg | 21,907 | $395K | 100% |
| Filing → |
| TBPH | SELL | 2018-09-14 | $364K | — | Filing → |